The Valley Desk

NCT04468659 · Interventional trial

AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

Overall registry status Active not recruiting

Phase 3

Conditions Early Preclinical Alzheimer's Disease, Preclinical Alzheimer's Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov